PhaseBio Pharmaceuticals, Inc. (PHAS)

Net Change in Cash

-$10.88M

Quarterly · Period ending: · USD

PHAS logo

PHAS Net Change in Cash

Latest reported-$10.88M
PHAS Quarterly Net Change in Cash (-$2.23M → -$10.88M)
High-resolution chart · PNG

PHAS net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-10,884,000
-23,112,000
-14,557,000
-8,099,000
-12,507,000
48,841,000
-11,231,000
-13,672,000
-6,416,000
-14,584,000
-7,746,000
-8,571,000
38,428,000
-9,137,000
36,710,000
15,607,000
-2,032,000
-2,640,000
9,129,000
-2,227,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.